SI-BONE files $98M IPO: 4 things to know

Written by Shayna Korol | September 21, 2018 | Print  |

Spinal implant manufacturer SI-BONE filed to raise up to $98 million in an initial public offering Sept. 20, according to Renaissance Capital.

Here are four things to know:

1. SI-BONE booked $52 million in revenue for the 12 months ending June 30.

2. Morgan Stanley and Bank of America Merrill Lynch are the deal’s joint bookrunners.

3. Pricing terms were not disclosed.

4. SI-BONE develops the iFuse Implant System, a minimally invasive sacroiliac joint disorder treatment.

More articles on devices:
NuVasive welcomes CEO of Google, Johnson & Johnson partnership company to board
Medtronic adds to spine business with $1.64B acquisition of Mazor: 6 things to know
SpineEx files for $17M IPO: 3 notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months